Glucagon-like peptide 1 therapy as an adjunct treatment after bariatric metabolic surgery: Preliminary experience from an East-Asian medical center

• Ting-Wei Chang,
• Ivy Ya-Wei Huang,
• Chih-Kun Huang,
• Po-Chih Chang

Affiliations

Ting-Wei Chang

Division of Thoracic Surgery, Department of Surgery, Kaohsiung Medical University Hospital/ Kaohsiung Medical University, Kaohsiung City, Taiwan

Ivy Ya-Wei Huang

Weight Management Center, Kaohsiung Medical University Hospital/ Kaohsiung Medical University, Kaohsiung City, Taiwan; Department of Nursing, Kaohsiung Medical University Hospital/ Kaohsiung Medical University, Kaohsiung City, Taiwan

Chih-Kun Huang

Body Science and Metabolic Disorders International Medical Center, China Medical University Hospital, Taichung City, Taiwan

Po-Chih Chang

Corresponding author. No. 100, Tzyou 1st Road, Kaohsiung City, 80756, Taiwan.; Division of Thoracic Surgery, Department of Surgery, Kaohsiung Medical University Hospital/ Kaohsiung Medical University, Kaohsiung City, Taiwan; Weight Management Center, Kaohsiung Medical University Hospital/ Kaohsiung Medical University, Kaohsiung City, Taiwan; Department of Sports Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan; Program in Biomedical Engineering, College of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan